8-K filing — Onconetix, Inc. (ONCO)
Filed: 2026-07-29 AccNo: 0001213900-26-082879 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Filings · News reference
Onconetix Files Prospectus For Resale Of Up To 100M Shares Issuable Upon Conversion Of Series F Preferred Stock, Or 2,532% Of Shares Outstanding
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular session. The market value of their outstanding shares is at $17.4 billion. The company's, Q2 earnings came out
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation
Onconetix announced that Realbotix, its pending acquisition target, has partnered with Bloom Procurement Services to launch a pilot program deploying socially assistive humanoid robots in UK care settings to address loneliness among elderly residents. Realbotix has been accredited as a supplier on Bloom's public sector marketplace. The acquisition is expected to close in the second half of 2026, subject to shareholder approval and regulatory clearances.